Andrew Bevan

As Senior Vice President of Medical Sales at Canopy Growth, Andrew Bevan oversees the Company’s global medical business across Canada, Europe, and Australia. Previously, Andrew led Canopy’s Canadian medical cannabis business under Spectrum Therapeutics, one of the country’s largest medical cannabis platforms, and played a key role in launching the Spectrum brand in Germany, Australia, Poland, Czechia, and the UK. 

With over two decades of experience in the healthcare industry, Andrew has held senior commercial and market access roles at GlaxoSmithKline and Janssen, where he successfully led brand strategy, sales execution, market expansion, and payer engagement initiatives. He has an outstanding track record in driving the growth and success of Canopy’s medical business, and under his leadership, Canopy is well-positioned to capture new opportunities on a global scale while further enhancing its ability to serve patients with high-quality medical cannabis products. Andrew holds a Specialized Honours Bachelor’s Degree in Kinesiology and Health Science from York University.